Effect of High-Intensity Gait Training Using a Treadmill on Locomotion Recovery in Traumatic Brain Injury Patients

November 11, 2022 updated by: Courtney Perkins, PT, DPT, Carilion Clinic
The project will consist of subjects who have suffered Traumatic Brain Injury (TBI) and who are able to ambulate on treadmill with or without a harness system. This will be a 4-week controlled study consisting of two groups of TBI patients, high-intensity intervention group and low-intensity control group. Both groups will receive physical therapy treatment 3 times per week for 1 hour. The intervention group will undergo 30-minute sessions of high-intensity walking on a treadmill with an overhead harness attached for safety. In addition, they will also get up to 30-minutes of low-intensity physical therapy in order to receive 1 hour of treatment time. The control group will undergo only low-intensity physical therapy activities for 1-hour. Low-intensity physical therapy will include strength exercises, stretches, balance, and low-intensity gait training. All participants in both groups will complete these outcome measures on the first day of the study, after 2 weeks of participation, and again at the end of 4 weeks or on their last day before discharge from Carilion's services. Later on, all participants in both groups will be followed up to complete the same set of outcome measures at the end of 1 month since completion of the protocol. This follow up session will take up to 45 minutes to complete.

Study Overview

Detailed Description

Gait, mobility and cognitive function will be first assessed using seven standardized performance-based outcome measures including both mobility and cognitive measures. All participants in both groups will complete these outcome measures on the first day of the study, after 2 weeks of participation, again at the end of 4 weeks, or on their last day before being discharged from Carilion's services, and 1 month after their 4 week completion.

Participants of the intervention group will undergo physical therapy for 3 days a week for 4 weeks, with each session lasting a total of 60 minutes. They will start with 30 minutes of high-intensity gait training (HIGT) followed by up to 30 minutes of low-intensity therapy. For HIGT, participants will be secured safely on a treadmill with or without an overhead harness and unweighting system for successful gait training. Their resting HR and BP would be noted. Participants would begin with a warmup for 3 minutes by walking at low speeds with intensity of 30-50% of heart rate reserve (HRR). HR would be monitored continuously from here onwards till the conclusion of the protocol. Following the warmup, treadmill walking speed will be initially set at target HR of 85%HRR that was noted from the treadmill test. If the participant did not reach 85% HRR during the treadmill test, treadmill speed would be set by subtracting 0.1 mph (or 0.1 treadmill workload unit) from the speed at which they started showing gait instability or backward drift during the treadmill test. The goal would be to have participants walk at high aerobic intensity with target HR between 60-85%HRR, ideally close to 85%HRR, for 25 minutes. The studies report that the closer the heart rate can be maintained to the 85% target HR, the more beneficial the training.

If a participant is unable to achieve at least 60%HRR in the first few minutes of high-intensity phase, the participant's feeling of physical exertion would also be measured by asking them about a score on the Rates of Perceived Exertion (RPE) scale of 0-10. Here the goal would be to have them maintain an exertion intensity score of 5-8. If needed, participants would be allowed to rest by standing or sitting down. The amount of time spent in high-intensity and rest periods would be recorded. BP will also be recorded at 15-minute and 25-minute timepoints, or during rest breaks. At conclusion of 25 minutes of HIGT, participants will cool down for 2 minutes by walking at 30-50% HRR. Their HR and BP will again be measured at the end of the cool down period. Besides HR and BP, participant's oxygen saturation would also be monitored during this protocol using a pulse oximeter to assess blood oxygen levels. Depending on the remaining time and activity tolerance levels, intervention group participants will then perform up to 30 minutes of low-intensity physical therapy until they have reached a total of 60 minutes for that session. These may consist of low-intensity gait activities, exercises (such as lower extremity strength training with or without weights or electrical stimulation, sit to stands from a chair, mat exercises for upper/lower extremities and core strength, etc.), stretches, balance, and other therapeutic activities (such as transfers, bed mobility training, etc.) for functional mobility.

Participants in the control group will receive 60-minute sessions of only low-intensity physical therapy for 3 days a week for 4 weeks. Here, the goal is to have the participants work at a lower intensity with a target HR below 60%HRR. Low-intensity physical therapy could include low-intensity gait activities, exercises (such as lower extremity strength training with or without weights or electrical stimulation, sit to stands from a chair, mat exercises for upper/lower extremities and core strength, etc.), stretches, balance, and other therapeutic activities (such as transfers, bed mobility training, etc.). During these sessions, HR and BP would be measured and noted at regular intervals to monitor and note the cardiorespiratory intensity of those activities.

Study Type

Interventional

Enrollment (Anticipated)

60

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • Virginia
      • Roanoke, Virginia, United States, 24014
        • Recruiting
        • Institute for Orthopaedics and Neurosciences
        • Contact:
          • Courtney Perkins

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 65 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Medical and treadmill screening clearance to participate in this study
  • Persons with mild, moderate, or severe Traumatic Brain Injury at onset (first time or repeats)
  • 18-65 years old persons who are able to ambulate on treadmill with or without assistive devices and with or without need for bodyweight-support harness system
  • Ability to communicate with investigators to follow protocol instructions and respond appropriately
  • Patients who have decision-making capacity and are able to consent for themselves

Exclusion Criteria:

  • Unstable orthopedic conditions, for example, unstable craniectomies or weight-bearing restrictions.
  • Unstable cardiac conditions including, unstable angina, unstable cardiac dysrhythmias, myocardial ischemia or hypertension at rest (systolic BP > 140mm Hg and diastolic BP >90 mm Hg, or if over this range, then a physician must clear patient for participation)
  • Acute systemic infection accompanied by fever, body aches or swollen lymph glands.
  • Hospitalization for acute cardiac, pulmonary or metabolic conditions in the past 3 months.
  • Any other physical or mental restrictions preventing participation in the research protocol.
  • Women who are pregnant are being excluded as this is considered a high risk study. They will be asked via verbal questioning via the following statements, "Are you currently pregnant?" or "Are you planning to become pregnant?".
  • Non-English Speakers

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: High-Intensity Treadmill Gait Training (HIGT)
High-intensity walking physical therapy with some low intensity therapy.
High Intensity Gait Training using treadmill and overhead harness for fall prevention
Active Comparator: Low Intensity Physical Therapy
Low-intensity gait activities, exercises (such as lower extremity strength training with or without weights or electrical stimulation, sit to stands from a chair, mat exercises for upper/lower extremities and core strength, etc.), stretches, balance training activities, and other therapeutic activities (such as transfers, bed mobility training, etc.).
Low Intensity Gait Activities

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Five Times Sit to Stand Test
Time Frame: Through intervention and follow-up period, up to 8 weeks. This would be administered at the beginning, at the end of 2 weeks, at the end of 4 weeks of interventions, and finally at the end of 4 weeks following end of interventions for follow-up.
Stand up and sit down as quickly as possible 5 times, keeping your arms folded across your chest.
Through intervention and follow-up period, up to 8 weeks. This would be administered at the beginning, at the end of 2 weeks, at the end of 4 weeks of interventions, and finally at the end of 4 weeks following end of interventions for follow-up.
Six Minute Walk Test (6MWT)
Time Frame: Through intervention and follow-up period, up to 8 weeks. This would be administered at the beginning, at the end of 2 weeks, at the end of 4 weeks of interventions, and finally at the end of 4 weeks following end of interventions for follow-up.
a sub-maximal exercise test used to assess walking endurance and aerobic capacity. Participants will walk around the perimeter of a set circuit for a total of six minutes.
Through intervention and follow-up period, up to 8 weeks. This would be administered at the beginning, at the end of 2 weeks, at the end of 4 weeks of interventions, and finally at the end of 4 weeks following end of interventions for follow-up.
10 Meter Walk Test (10mWT)
Time Frame: Through intervention and follow-up period, up to 8 weeks. This would be administered at the beginning, at the end of 2 weeks, at the end of 4 weeks of interventions, and finally at the end of 4 weeks following end of interventions for follow-up.
Assesses walking speed in meters/second (m/s) over a short distance.
Through intervention and follow-up period, up to 8 weeks. This would be administered at the beginning, at the end of 2 weeks, at the end of 4 weeks of interventions, and finally at the end of 4 weeks following end of interventions for follow-up.
Berg Balance Scale (BBS)
Time Frame: Through intervention and follow-up period, up to 8 weeks. This would be administered at the beginning, at the end of 2 weeks, at the end of 4 weeks of interventions, and finally at the end of 4 weeks following end of interventions for follow-up.
Used to objectively determine a patient's ability (or inability) to safely balance during a series of predetermined tasks. The minimum value of this assessment is 0, and the maximum is 56. A higher score means a better outcome.
Through intervention and follow-up period, up to 8 weeks. This would be administered at the beginning, at the end of 2 weeks, at the end of 4 weeks of interventions, and finally at the end of 4 weeks following end of interventions for follow-up.
Timed Up and Go (TUG)
Time Frame: Through intervention and follow-up period, up to 8 weeks. This would be administered at the beginning, at the end of 2 weeks, at the end of 4 weeks of interventions, and finally at the end of 4 weeks following end of interventions for follow-up.
Assesses a person's mobility that requires both static and dynamic balance.
Through intervention and follow-up period, up to 8 weeks. This would be administered at the beginning, at the end of 2 weeks, at the end of 4 weeks of interventions, and finally at the end of 4 weeks following end of interventions for follow-up.
Timed Up and Go (Cognitive)
Time Frame: Through intervention and follow-up period, up to 8 weeks. This would be administered at the beginning, at the end of 2 weeks, at the end of 4 weeks of interventions, and finally at the end of 4 weeks following end of interventions for follow-up.
Complete a TUG test while counting backward by three from a randomly selected number between 20 and 100.
Through intervention and follow-up period, up to 8 weeks. This would be administered at the beginning, at the end of 2 weeks, at the end of 4 weeks of interventions, and finally at the end of 4 weeks following end of interventions for follow-up.
Montreal Cognitive Assessment (MoCA)
Time Frame: Through intervention and follow-up period, up to 8 weeks. This would be administered at the beginning, at the end of 2 weeks, at the end of 4 weeks of interventions, and finally at the end of 4 weeks following end of interventions for follow-up.
A rapid screening instrument for mild cognitive dysfunction. The minimum value of this assessment is 0, and the maximum is 30. A higher score means a better outcome.
Through intervention and follow-up period, up to 8 weeks. This would be administered at the beginning, at the end of 2 weeks, at the end of 4 weeks of interventions, and finally at the end of 4 weeks following end of interventions for follow-up.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Principal Investigator: Courtney Perkins, DPT, Carilion Clinic

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 7, 2022

Primary Completion (Anticipated)

October 6, 2024

Study Completion (Anticipated)

October 6, 2024

Study Registration Dates

First Submitted

October 20, 2022

First Submitted That Met QC Criteria

November 11, 2022

First Posted (Actual)

November 21, 2022

Study Record Updates

Last Update Posted (Actual)

November 21, 2022

Last Update Submitted That Met QC Criteria

November 11, 2022

Last Verified

November 1, 2022

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Traumatic Brain Injury

Clinical Trials on HIGT - physical rehab

3
Subscribe